Important Cookie Information – This message will only appear once. DrugDev websites use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and their use, please see our Privacy Policy.
drugdev.com was registered 1 decade 6 years ago. It has a alexa rank of #1,250,635 in the world. It is a domain having .com extension. It is estimated worth of $ 960.00 and have a daily income of around $ 4.00. As no active threats were reported recently, drugdev.com is SAFE to browse.
Daily Unique Visitors: | 701 |
Daily Pageviews: | 1,402 |
Income Per Day: | $ 4.00 |
Estimated Worth: | $ 960.00 |
Google Indexed Pages: | Not Applicable |
Yahoo Indexed Pages: | Not Applicable |
Bing Indexed Pages: | Not Applicable |
Google Backlinks: | Not Applicable |
Bing Backlinks: | Not Applicable |
Alexa BackLinks: | Not Applicable |
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: | Very Poor |
WOT Privacy: | Very Poor |
WOT Child Safety: | Very Poor |
Alexa Rank: | 1,250,635 |
PageSpeed Score: | 89 ON 100 |
Domain Authority: | 49 ON 100 |
Bounce Rate: | Not Applicable |
Time On Site: | Not Applicable |
DrugDev: We are transforming the clinical trial landscape and enable companies to “do more trials”. View company info, jobs, team members, culture, funding ...
Jan 25, 2017 ... DrugDev Spark Introduced As The First Comprehensive Unified Suite Of Proven Solutions For Clinical Operations ... For years, the pharmaceutical ...
Error wrong password. Login to DrugDev Payments Portal Lorem ipsum dolor sit amet, consectetur adipisicing elit. Username.
Feb 5, 2018 ... The company more than doubled new business orders as adoption of the DrugDev Spark™ clinical operations suite continues to steadily climb to ...
Information on acquisition, funding, cap tables, investors, and executives for DrugDev. Use the PitchBook Platform to explore the full profile.
May 10, 2017 ... Citeline's nearly 400000 global investigators – paired with DrugDev's ... Trials by Integrating Citeline Investigator Data with DrugDev Spark™.
DrugDev's top competitors include Greenphire, Clinverse and Clintrax Global. See the full list of DrugDev competitors, plus revenue, employees, and funding ...
DrugDev Inc. DrugDev Inc. provides research and development services. The Company involves in the discovery of new drugs, as well as offers clinical trials and ...
The latest Tweets from Drug Dev (@drugdev_boston). DrugDev, an IQVIA company, is committed to providing sponsors, CROs and sites with solutions that ...
Technology to Transform Your Clinical Trials DrugDev, now part of IQVIA Technologies, offers the world's first unified clinical operations suite comprised of ...
About. DrugDevs' innovative clinical trial technology provides cloud-based proven solutions used on thousands of trials. Learn more. Website. https://www. drugdev ...
Jun 6, 2018 ... Melissa "Liss" Easy, the founder of DrugDev, shares her insights on the role of technology in clinical research. We discuss about remote teams, ...
Aug 25, 2016 ... Gallagher & Davis represent DrugDev in relocation to 16,437 SF in the Innovation District. NAI Hunneman recently completed a 16,437 SF ...
Jun 26, 2017 ... DrugDev, which was founded in 2009, has built an integrated suite of technologies through acquisitions of CFS Clinical, TrialNetworks and ...
Garth Little's email address g******@drugdev.com 215-919-.... | Show email & phone number >>>
Register with the DrugDev network and create a complementary profile in our network for full access to study sponsors and CROs who are seeking sites like ...
drug-dev.com — Catalent recently announced it has made an investment to expand capabilities at its clinical supply services facility in Philadelphia to support ...
From site selection and activation to site payments, eConsent and LMS, DrugDev technology has been proven to transform the quality and efficiency of thousands ...
INC Research and DrugDev Create Cloud-Based Solutions ... entered into a strategic collaboration with DrugDev to drive increased efficiencies in clinical trials ...
DrugDev has 193 employees across 2 locations. See insights on DrugDev including office locations, competitors, revenue, financials, executives, subsidiaries ...
H1 Headings: | 1 | H2 Headings: | 1 |
H3 Headings: | 4 | H4 Headings: | Not Applicable |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | Not Applicable | Total Images: | 2 |
Google Adsense: | Not Applicable | Google Analytics: | UA-52311320-1 |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
Contact Us | 3 | 1.429 % | No |
See More | 3 | 1.429 % | No |
| 2 | 0.952 % | No |
Site Payments | 2 | 0.952 % | No |
Investigators | 2 | 0.952 % | No |
Investigators Contact | 2 | 0.952 % | No |
investigators with | 1 | 0.476 % | No |
the industry | 1 | 0.476 % | No |
with the | 1 | 0.476 % | No |
and investigators | 1 | 0.476 % | No |
global sites | 1 | 0.476 % | No |
the truth | 1 | 0.476 % | No |
truth of | 1 | 0.476 % | No |
of global | 1 | 0.476 % | No |
industry standard DrugDev | 1 | 0.476 % | No |
sites and | 1 | 0.476 % | No |
Golden Number | 1 | 0.476 % | No |
Company Contact | 1 | 0.476 % | No |
Us Privacy | 1 | 0.476 % | No |
Privacy Policy | 1 | 0.476 % | No |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
Investigators Contact Us | 2 | 0.952 % | No |
Investigators Contact | 2 | 0.952 % | No |
and investigators with the | 1 | 0.476 % | No |
sites and investigators with | 1 | 0.476 % | No |
investigators with the industry | 1 | 0.476 % | No |
the industry standard DrugDev Golden | 1 | 0.476 % | No |
global sites and investigators | 1 | 0.476 % | No |
with the industry standard DrugDev | 1 | 0.476 % | No |
truth of global sites | 1 | 0.476 % | No |
source of the truth | 1 | 0.476 % | No |
of the truth of | 1 | 0.476 % | No |
the truth of global | 1 | 0.476 % | No |
industry standard DrugDev Golden Number | 1 | 0.476 % | No |
of global sites and | 1 | 0.476 % | No |
Golden Number T An | 1 | 0.476 % | No |
Contact Us Privacy Policy | 1 | 0.476 % | No |
Us Privacy Policy Privacy | 1 | 0.476 % | No |
Privacy Policy Privacy Shield | 1 | 0.476 % | No |
Policy Privacy Shield Do | 1 | 0.476 % | No |
Company Contact Us Privacy | 1 | 0.476 % | No |
DrugDevs' innovative clinical trial technology provides cloud-based proven solutions used on thousands of trials. Learn more.
Domain Registrar: | GoDaddy.com, LLC |
---|---|
Registration Date: | 2008-04-24 1 decade 6 years 6 months ago |
Last Modified: | 2021-03-30 3 years 7 months 2 weeks ago |
Host | Type | TTL | Extra |
---|---|---|---|
drugdev.com | A | 295 |
IP: 104.155.133.196 |
drugdev.com | NS | 86400 |
Target: ns-1742.awsdns-25.co.uk |
drugdev.com | NS | 86400 |
Target: ns-244.awsdns-30.com |
drugdev.com | NS | 86400 |
Target: ns-598.awsdns-10.net |
drugdev.com | NS | 86400 |
Target: ns-1487.awsdns-57.org |
drugdev.com | SOA | 900 |
MNAME: ns-1487.awsdns-57.org RNAME: awsdns-hostmaster.amazon.com Serial: 1 Refresh: 7200 Retry: 900 Expire: 1209600 |
drugdev.com | MX | 300 |
Priority: 10 Target: alt3.aspmx.l.google.com |
drugdev.com | MX | 300 |
Priority: 5 Target: alt1.aspmx.l.google.com |
drugdev.com | MX | 300 |
Priority: 5 Target: alt2.aspmx.l.google.com |
drugdev.com | MX | 300 |
Priority: 1 Target: aspmx.l.google.com |
drugdev.com | TXT | 300 |
TXT: v=spf1 include:_spf.google.com ~all |
drugdev.com | TXT | 300 |
TXT: pardot_288682_*=1911314934fe2494825e18aa 25658596ba73f29b7e04de11361b068a49547f61 |
Check iPhone imei number simlock status, apple warranty and activation
Дипломные под заказ - заказать дипломную работу ★За 16 лет работы написали 27355 курсовых и 2314 дипломных работ★ Обращайся к профессионалам ☎ (093) 107-18-04
Connecting New York City with stories for the millennial generation. Check out for a refreshing take of spoiled NYC.
▷Productora audiovisual de Madrid : Tu vídeo DESDE 350€ con Guion GRATIS. Más de 10 años en proyectos para Carrefour y Rodilla entre otros.
We were started by high volume media buyers who wanted to optimize performance and noticed a gap in the information available.